http://www.immunologyproductguide.com/blog A comprehensive guide to immunology products for medical professionals Fri, 11 Jun 2010 10:09:04 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 http://www.immunologyproductguide.com/blog/2008/07/09/novartis-vaccine-shows-stronger-immune-response-against-meningococcal-strains/ http://www.immunologyproductguide.com/blog/2008/07/09/novartis-vaccine-shows-stronger-immune-response-against-meningococcal-strains/#comments Wed, 09 Jul 2008 19:47:16 +0000 Jim Marino http://www.immunologyproductguide.com/blog/2008/07/09/novartis-vaccine-shows-stronger-immune-response-against-meningococcal-strains/ New Phase III data released by Novartis Pharmaceuticals showed that its under-development vaccine against four types of meningococcal strains produces a better antibody response than a commonly used existing vaccine. New Phase III data for Menveo® (MenACWY-CRM) depicts that the vaccine produced a greater immune response against meningococcal strains A, C, W-135 and Y in adolescents aged between 11 and 18 years, as compared to Sanofi Pasteur’s Menactra®. Infection with any of these four vaccine-preventable serogroups (strains) can lead to bacterial meningitis, an infection of the membrane around the brain and spinal cord, or sepsis, a serious infection of the blood stream.

]]> http://www.immunologyproductguide.com/blog/2008/07/09/novartis-vaccine-shows-stronger-immune-response-against-meningococcal-strains/feed/ 0